14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
Mar 27, 2019 $22.56 $22.71 $21.76 $22.01 456 315
Mar 26, 2019 $22.45 $22.75 $21.97 $22.62 506 142
Mar 25, 2019 $22.33 $22.60 $21.30 $22.17 659 357
Mar 22, 2019 $22.01 $22.14 $21.44 $21.48 618 593
Mar 21, 2019 $21.15 $22.22 $20.94 $22.07 435 281
Mar 20, 2019 $21.66 $21.82 $21.08 $21.15 443 401
Mar 19, 2019 $22.33 $22.62 $21.60 $21.67 767 089
Mar 18, 2019 $23.00 $23.29 $22.10 $22.40 971 991
Mar 15, 2019 $23.44 $23.67 $23.27 $23.46 627 098
Mar 14, 2019 $23.66 $24.12 $23.32 $23.34 567 869
Mar 13, 2019 $23.41 $23.86 $23.05 $23.65 583 529
Mar 12, 2019 $23.12 $23.56 $22.85 $23.33 405 781
Mar 11, 2019 $23.55 $23.55 $22.82 $23.05 779 500
Mar 08, 2019 $23.16 $23.44 $22.70 $23.36 404 103
Mar 07, 2019 $23.49 $23.73 $22.66 $23.41 557 450
Mar 06, 2019 $25.44 $25.45 $23.40 $23.49 854 221
Mar 05, 2019 $24.85 $25.80 $24.60 $25.48 640 601
Mar 04, 2019 $24.29 $25.81 $24.29 $24.78 929 649
Mar 01, 2019 $23.80 $24.94 $22.81 $24.89 1 074 259
Feb 28, 2019 $25.02 $25.16 $24.03 $24.09 676 463
Feb 27, 2019 $24.63 $25.53 $24.24 $24.91 858 152
Feb 26, 2019 $24.13 $24.87 $23.90 $24.62 580 807
Feb 25, 2019 $24.00 $24.32 $23.40 $24.26 617 999
Feb 22, 2019 $22.91 $23.73 $22.75 $23.72 522 116
Feb 21, 2019 $23.22 $23.54 $22.67 $22.93 480 562
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT